Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data by Szu-Chun Yang, Jung-Der Wang, Shi-Yi Wang

Get full text

Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer by Szu-Chun Yang, Szu-Chun Yang, Natalia Kunst, Natalia Kunst, Natalia Kunst, Cary P. Gross, Jung-Der Wang, Wu-Chou Su, Shi-Yi Wang, Shi-Yi Wang

Get full text

Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer by Szu‐Chun Yang, Huang‐Tz Ou, Wu‐Chou Su, Shi‐Yi Wang

Get full text

Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma by Szu-Chun Yang, Chien-Chung Lin, Yi-Lin Chen, Yi-Lin Chen, Wu-Chou Su

Get full text

Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan. by Szu-Chun Yang, Wu-Wei Lai, Jason C Hsu, Wu-Chou Su, Jung-Der Wang

Get full text

Estimation of disability free life expectancy in non small cell lung cancer based on real world data by Shin-Mao Lin, Szu-Chun Yang, Tzu-I. Wu, Jung-Der Wang, Li-Fan Liu

Get full text

QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon by Wu-Wei Lai, Chia-Hua Chung, Chia-Ni Lin, Szu-Chun Yang, Jing-Shiang Hwang, Jung-Der Wang

Get full text

Indigenous recurrent disseminated histoplasmosis in Taiwan by Hung-I Kuo, Xin-Min Liao, Szu-Chun Yang, Jen-Chieh Lee, Kung-Chao Chang, Cong-Tat Cia

Get full text

Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study by Jason C Hsu, Chen-Fang Wei, Szu-Chun Yang, Peng-Chan Lin, Yang-Cheng Lee, Christine Y Lu

Get full text

Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program by Chin-Wei Kuo, Chuan-Yu Chen, Chih-Hsing Wu, Chang-Wen Chen, Fei-Ran Guo, Szu-Chun Yang

Get full text

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis. by Wei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, Szu-Chun Yang, Chien-Chung Lin, Wu-Chou Su

Get full text

Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer by Szu-Chun Yang, Chien-Chung Lin, Wu-Wei Lai, Sheng-Mao Chang, Jing-Shiang Hwang, Wu-Chou Su, Jung-Der Wang

Get full text

Estimating time and transportation costs associated with lung cancer screening and diagnostic lung procedures in Taiwan: a cross-sectional survey in a medical centre by Szu-Chun Yang, Chien-Yu Lin, Ting-Hsing Chao, Chi-Hao Wu, Li-Jung Elizabeth Ku, Ta-Jung Chung, Hui-Ju Liu

Get full text

Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio by Jeng-Shiuan Tsai, Sheng-Huan Wei, Chian-Wei Chen, Szu-Chun Yang, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin, Wu-Chou Su

Get full text

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer by Po-Lan Su, Yi-Lin Wu, Wei-Yuan Chang, Chung-Liang Ho, Yau-Lin Tseng, Wu-Wei Lai, Wu-Chou Su, Chien-Chung Lin, Szu-Chun Yang

Get full text

Improved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors by Sheng‐Yuan Wang, Ching‐Han Lai, Chian‐Wei Chen, Szu‐Chun Yang, Chao‐Chun Chang, Chia‐Ying Lin, Yi‐Ting Yen, Yau‐Lin Tseng, Po‐Lan Su, Chien‐Chung Lin, Wu‐Chou Su

Get full text

Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs by Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin, Chien-Feng Li, Shang-Yin Wu, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Wu-Chou Su

Get full text

The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study by Jason C. Hsu, Phung-Anh Nguyen, Phung-Anh Nguyen, Yen-Tzu Chen, Szu-Chun Yang, Chien-Chung Lin, Yi-Hsin Yang, Yu-Chao Lin, Te-Chun Hsia, Hsing-Chun Hsieh, Hsing-Chun Hsieh, Jia-Syuan Wu, Chi-Pei Chang, Yin-Hsun Feng, Peng-Chan Lin, Ping-Chih Hsu, Huey-En Tzeng, Shu-Chen Chien, Wei-Chiao Chang, Chih-Cheng Chang, Hsuan-Chia Yang, Chueh Ming Lee, Christine Y. Lu

Get full text